Abstract
Abstract
Purpose of Review
The goal of this paper is to review drug allergy alert systems (DAAS), to summarise their key components, and to overview potential benefits and challenges associated with these tools. Methods for validation of their effects on patient safety, alternative uses, and strategies to streamline DAAS’ functions and reduce system fatigue are discussed.
Recent Findings
DAAS are clinical decision support systems (CDSS) that focus on preventing drug adverse events within healthcare settings. The advent of electronic medical records has facilitated the development of digital DAAS. Existing versions use different methods to document diagnosed allergies, and rely on distinct rules and matching strategies for the generation of real-time alerts. DAAS promote the automation of several processes, facilitate prompt patient referral, and may be customised. Information overload, alert overrides by clinicians, and the development of “alert fatigue” may interfere with their usefulness. The newest strategies to streamline the function of DAAS include the use of artificial intelligence (AI) and other predictive techniques.
Summary
The rising prevalence of drug allergies underscores the importance of effective DAAS. Further research is needed to evaluate their usefulness, to optimise their performance, to explore different algorithms and data sources, and to enhance the standardised integration of these systems into clinical practice.
Publisher
Springer Science and Business Media LLC
Subject
Medicine (miscellaneous),Immunology and Allergy
Reference44 articles.
1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA J Am Med Assoc. 1995;274(1):29–34.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. J Am Med Assoc. 1998;279(15):1200–5.
3. WHO Meeting on International Drug Monitoring: The Role of National Centers & World Health Organization. International drug monitoring: the role of national centers, report of a WHO meeting (held in Geneva from 20 to 25 September 1971) [Internet]. World Health Organ Tech Rep Ser. 1972
4. 498: 1-25. [access July 22th, 2023]. Available in: https://apps.who.int/iris/handle/10665/40968.
5. Vervloet D, Thong B. Drug Allergies | World Allergy Organization [Internet]. World Allergy Organization Allergy Organization. 2021 [cited 2023 Jul 17]. Available from: https://www.worldallergy.org/education-and-programs/education/allergic-disease-resource-center/professionals/drug-allergies. Accessed 17 July 2023.